Clinical Research Directory
Browse clinical research sites, groups, and studies.
Systemic Antifungal Plus Q-Switched Nd:YAG Laser for Onychomycosis
Sponsor: Assiut University
Summary
This randomized controlled trial aims to compare the efficacy and safety of systemic terbinafine combined with Q-switched Nd:YAG laser versus systemic terbinafine alone in the treatment of onychomycosis.
Official title: Systemic Antifungal Therapy Combined With Q-Switched Nd:YAG Laser Versus Systemic Antifungal Therapy Alone in the Treatment of Onychomycosis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
97
Start Date
2026-10-10
Completion Date
2028-02-10
Last Updated
2026-10-09
Healthy Volunteers
No
Conditions
Interventions
Terbinafine
Oral terbinafine 250 mg once daily for 6 weeks (fingernails) or 12 weeks (toenails).
Q-switched Nd:YAG laser
Q-switched Nd:YAG laser (1064 nm) applied to the affected nail plate, 4 passes per session, every 2 weeks for 6 sessions.